Mar 31, 2012

United Therapeutics Q1 2012 Earnings Report

Total Revenue
$204M
Previous year: $166M
+23.3%
EPS
$1.32
Previous year: $0.28
+371.4%
Gross Profit
$180M
Previous year: $144M
+25.0%
Cash and Equivalents
$157M
Previous year: $289M
-45.8%
Free Cash Flow
-$2.7M
Previous year: $47M
-105.7%
Total Assets
$1.56B
Previous year: $1.49B
+5.1%

United Therapeutics

United Therapeutics